| Followers | 37 |
| Posts | 15270 |
| Boards Moderated | 0 |
| Alias Born | 08/29/2012 |
Monday, February 19, 2024 4:33:58 AM
Nasrat answered my question during the CC (of course he did - he knows I'm The King).
He confirmed what I posted back on January 20:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173667983
Therefore, please update the three "Tagi" sections of the iBox to "Precision Dose".
Marketed By
Old: Tagi
Old: Tagi
Old: Tagi
New: Precision Dose
New: Precision Dose
New: Precision Dose
The ELTP King: "I noticed in November 2023 that our three products with TAGI were changed from the TAGI label to the Precision Dose label. What was the reason for the label change?"
Nasrat: "Well, the honest reason is that because our partner/client requested it, said hey we want to call ourselves Precision Dose only from now on. Then they changed their mind and they want to keep some under TAGI. But that's really as far as we're concerned. They asked us to do this to start selling it, we'll do it. But the rest of the story is that the gentleman who started TAGI retired and sold his share to Precision Dosing. And now it's Precision Dose that owns both companies, and I think they are transitioning to one name only. There is no impact on Elite whatsoever."
He confirmed what I posted back on January 20:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173667983
Therefore, please update the three "Tagi" sections of the iBox to "Precision Dose".
Marketed By
Old: Tagi
Old: Tagi
Old: Tagi
New: Precision Dose
New: Precision Dose
New: Precision Dose
The ELTP King: "I noticed in November 2023 that our three products with TAGI were changed from the TAGI label to the Precision Dose label. What was the reason for the label change?"
Nasrat: "Well, the honest reason is that because our partner/client requested it, said hey we want to call ourselves Precision Dose only from now on. Then they changed their mind and they want to keep some under TAGI. But that's really as far as we're concerned. They asked us to do this to start selling it, we'll do it. But the rest of the story is that the gentleman who started TAGI retired and sold his share to Precision Dosing. And now it's Precision Dose that owns both companies, and I think they are transitioning to one name only. There is no impact on Elite whatsoever."
BLUE LIVES MATTER.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/01/2026 11:00:24 AM
- Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product • Newsfile • 06/01/2026 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
